TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 133 resultados LastUpdate Última actualización 15/12/2019 [16:19:00] pdf PDF

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days

previousPage Página2 de 6 nextPage   por página


METHOD AND APPARATUS FOR ASSESSING DIABETIC CIRCULATORY COMPLICATIONS

NºPublicación: EP3573521A1 04/12/2019

Solicitante:

MODULATED IMAGING INC [US]

KR_20190133026_A

Resumen de: WO2018175787A1

Systems and methods directed to the assessment of circulatory complications due to advancement of diabetes. Embodiments include an optical measurement device having a light source with one or more wavelengths and configured to illuminate an area of tissue, a detector configured to capture the light reflecting from one or more layers of the tissue at the one or more illumination wavelengths, a processor configured to compute, based on the detected signal of layer extracted circulatory data, one or more estimates of tissue vascular health, and a display or communication device (e.g., electronic data transfer) configured to store or report the tissue vascular health. In exemplary embodiments, the distribution of chromophores such as hemoglobin in different layers of skin is extracted using a combination of structured light in the visible and near-infrared regime.

traducir

METHOD OF AND SYSTEM FOR STABILIZATION OF SENSORS

NºPublicación: US2019357816A1 28/11/2019

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2017079564_A1

Resumen de: US2019357816A1

A blood glucose sensing system includes a sensor and a sensor electronics device. The sensor includes a plurality of electrodes. The sensor electronics device includes stabilization circuitry. The stabilization circuitry causes a first voltage to be applied to one of the electrodes for a first timeframe and causes a second voltage to be applied to one of the electrodes for a second timeframe. The stabilization circuitry repeats the application of the first voltage and the second voltage to continue the anodic—cathodic cycle. The sensor electronics device may include a power supply, a regulator, and a voltage application device, where the voltage application device receives a regulated voltage from the regulator, applies a first voltage to an electrode for the first timeframe, and applies a second voltage to an electrode for the second timeframe.

traducir

ANALYTE SENSOR

NºPublicación: US2019357827A1 28/11/2019

Solicitante:

DEXCOM INC [US]

US_2018325437_A1

Resumen de: US2019357827A1

Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.

traducir

MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS

NºPublicación: US2019357813A1 28/11/2019

Solicitante:

MASIMO CORP [US]

US_2019374135_A1

Resumen de: US2019357813A1

The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

traducir

SENSOR MONITORING SYSTEM FOR IN-DWELLING CATHETER BASED TREATMENTS

NºPublicación: US2019358387A1 28/11/2019

Solicitante:

GASTROKLENZ INC [US]

WO_2019118929_PA

Resumen de: US2019358387A1

A patient monitoring system may be used with catheters to monitor the infusion and drainage of any solution into the human body. The system may be used, for example, with in-dwelling catheters for peritoneal dialysis in end stage renal disease (ESRD) patients, urinary tract catheters, insulin pumps in diabetic patients, feeding tubes and central venous line catheters. The patient monitoring system includes one or more fluid pathways for infusing into and/or draining solutions out of the catheter, and one or more sensors to monitor the fluid. The patient monitoring system transmits the patient monitoring data to a database, allowing data storage, processing, and access through graphical user interfaces to patients and providers via device applications or browser-based web access portals.

traducir

MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS

NºPublicación: US2019357812A1 28/11/2019

Solicitante:

MASIMO CORP [US]

US_2019374135_A1

Resumen de: US2019357812A1

The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

traducir

METHOD AND SYSTEM FOR MONITORING A DIABETES TREATMENT PLAN

NºPublicación: SG11201909689TA 28/11/2019

Solicitante:

CHAN SIDNEY SOONG LING [SG]

WO_2018232487_PA

Resumen de: SG11201909689TA

WO 18/ 23 2487 Al -Time Intervals for Ile, Measured A1c — Terse 1115 - Blood Glucose ON• -Model—Formulas and Time Int. 127 to evaluate predicted Plc 125 Apply BFM and adjustment factor to calculate predicted FI G.2 Upload New Measured Alc Upload New Blood Glucose Data Ouput re;cted Alc ' pee. 111 Obtain plurality of BGavE valu„ 1E1 Glucose data 131 Don pred15350 Output predicted alc excestl555551ation and escalelon alert to threshok13 ontli1.5511555 U5 I/155015E5d 5111314:5151 (BM) by selectlng 5155151with lawn ever.\" varlance between cal51.551 AU memund1115 123 Calculate accordingto eFM Determine adjustment factor for BFM (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 27 December 2018 (27.12.2018) WIP0 I PCT omit VIII °nolo III minim IH mo Imo oimIE (10) International Publication Number WO 2018/232487 Al (51) International Patent Classification: GO6Q 50/22 (2018.01) GOOF 19/00 (2018.01) G16H 20/00 (2018.01) G16H 10/60 (2018.01) A61B 90/00 (2016.01) A61B 5/145 (2006.01) (21) International Application Number: PCT/CA2017/050753 (22) International Filing Date: 20 June 2017 (20.06.2017) (25) Filing Language: English (26) Publication Language: English (72) Inventor; and (71) Applicant: CHAN, Sidney Soong-Ling [CA/SG]; 33-01, 53 Cairnhill Road, Singapore 229664 (SG). (74) Agent: EDWARDS, Antony C.; 400-444 7 Avenue SW, Calgary, Alberta

traducir

FLOWOMETRY IN OPTICAL COHERENCE TOMOGRAPHY FOR ANALYTE LEVEL ESTIMATION

NºPublicación: US2019357823A1 28/11/2019

Solicitante:

MASIMO CORP [US]

US_2018064381_A1

Resumen de: US2019357823A1

Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.

traducir

Methods and Systems for Improving the Reliability of Orthogonally Redundant Sensors

NºPublicación: US2019357820A1 28/11/2019

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2019343434_A1

Resumen de: US2019357820A1

Methods and systems for sensor calibration and sensor glucose (SG) fusion are used advantageously to improve the accuracy and reliability of orthogonally redundant glucose sensor devices, which may include optical and electrochemical glucose sensors. Calibration for both sensors may be achieved via fixed-offset and/or dynamic regression methodologies, depending, e.g., on sensor stability and Isig-Ratio pair correlation. For SG fusion, respective integrity checks may be performed for SG values from the optical and electrochemical sensors, and the SG values calibrated if the integrity checks are passed. Integrity checks may include checking for sensitivity loss, noise, and drift. If the integrity checks are failed, in-line sensor mapping between the electrochemical and optical sensors may be performed prior to calibration. The electrochemical and optical SG values may be weighted (as a function of the respective sensor's overall reliability index (RI)) and the weighted SGs combined to obtain a single, fused SG value.

traducir

TRANSCUTANEOUS ANALYTE SENSOR

NºPublicación: US2019357821A1 28/11/2019

Solicitante:

DEXCOM INC [US]

US_2019246965_A1

Resumen de: US2019357821A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

traducir

SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA

NºPublicación: US2019357852A1 28/11/2019

Solicitante:

DEXCOM INC [US]

US_2014114154_A1

Resumen de: US2019357852A1

Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.

traducir

DIABETES RISK ENGINE AND METHODS THEREOF FOR PREDICTING DIABETES PROGRESSION AND MORTALITY

NºPublicación: US2019357853A1 28/11/2019

Solicitante:

SHI LIZHENG [US]
FONSECA VIVIAN A [US]
SHAO HUI [US]

Resumen de: US2019357853A1

The present disclosure provides for diabetes risk engine systems and methods for predicting diabetes progression and mortality in a patient with type 2 diabetes mellitus, for the U.S. population, including the building, relating, assessing, and validating outcomes (BRAVO) risk engine. The BRAVO risk engine includes a diabetes-related events module to predict an occurrence of one or more events, a risk factors module to predict a progression of risk factors, a mortality module to predict an occurrence of mortality, and a display interface configured to display the predicted risk of diabetes-related events or mortality. Risk equations for predicting diabetes-related microvascular and macrovascular events, hypoglycemia, mortality, and progression of diabetes risk factors were estimated using the data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. The BRAVO risk engine preferably includes risk factors including severe hypoglycemia and common U.S. racial/ethnicity categories, compared to the UKPDS risk engine.

traducir

AUTOMATED SYSTEM FOR MONITORING A PATIENT'S BLOOD SUGAR

NºPublicación: WO2019224447A1 28/11/2019

Solicitante:

COMMISSARIAT ENERGIE ATOMIQUE [FR]

FR_3081316_A1

Resumen de: WO2019224447A1

The invention relates to an automated system for monitoring a patient's blood sugar, comprising a blood sugar sensor (101), a device (107) for measuring a physical activity of the patient, and a processing and control unit (105), in which: the processing and control unit (105) is configured to generate, by convolution of a signal PA provided by the device for measuring a physical activity of the patient with a decreasing mathematical function H, a signal IPA representing the influence of the physical activity of the patient on their insulin sensitivity; and the processing and control unit (105) is configured to calculate, on the basis of a first mathematical model fCR specific to the patient and taking into account the signal IPA and a single blood sugar value Gr measured by the sensor (101), a coefficient CR representing the insulin sensitivity of the patient.

traducir

AUTOMATED SYSTEM FOR MONITORING A PATIENT'S BLOOD SUGAR

NºPublicación: WO2019224446A1 28/11/2019

Solicitante:

COMMISSARIAT ENERGIE ATOMIQUE [FR]

FR_3081315_A1

Resumen de: WO2019224446A1

The invention relates to an automated system for monitoring a patient's blood sugar, comprising a blood sugar sensor (101) and a processing and control unit (105), in which the processing and control unit (105) is configured to calculate, on the basis of a first mathematical model fCR specific to the patient and taking into account a single blood sugar value Gr measured by the sensor, a coefficient CR representing the insulin sensitivity of the patient.

traducir

A GLUCOSE MULTI-VITAL-SIGN SYSTEM IN AN ELECTRONIC MEDICAL RECORDS SYSTEM

NºPublicación: WO2019226273A1 28/11/2019

Solicitante:

VITAL USA INC [US]

US_2019350469_A1

Resumen de: WO2019226273A1

A device measures blood glucose levels, temperature, heart rate, heart rate variability, respiration, SpO2, blood flow, blood pressure, total hemoglobin (SpHb), PVi, methemoglobin (SpMet), acoustic respiration rate (RRa), carboxyhemoglobin (SpCO), oxygen reserve index (ORi), oxygen content (SpOC) and/or EEG of a human.

traducir

FLUORESCENT GEL FOR GLUCOSE DETECTION AND CONTINUOUS GLUCOSE MONITORING METHOD USING SAME

NºPublicación: EP3572800A1 27/11/2019

Solicitante:

UNIV TOKYO [JP]

JP_2018116043_A

Resumen de: EP3572800A1

[Problem]The present invention addresses the problem of providing: a novel fluorescent gel for glucose monitoring, whereby a concentration of glucose in a living body can be continuously measured and fibrosis of the gel can be suppressed even when the gel is implanted for a long period of time; and continuous glucose monitoring using the fluorescent gel.[Solution]A fluorescent gel for glucose monitoring, having a three-dimensional mesh structure in which a plurality of four-armed polymers having a polyethylene glycol skeleton are crosslinked at terminal ends thereof, wherein a fluorescent dye unit exhibiting a fluorescence response by bonding with glucose is immobilized in the gel structure by covalent bonding.

traducir

HANDS DISPLAY OF SMARTWATCH FOR GLUCOSE MONITORING

NºPublicación: EP3573070A1 27/11/2019

Solicitante:

MANUFACTURE MODULES TECH SA [CH]

Resumen de: EP3573070A1

A smartwatch is configured for continuous glucose monitoring in the blood of an intended user using the smartwatch, the smartwatch comprising an analog display with a large hand and a small hand which are configured to show the time in a conventional manner; a control means configured to adjust the time by causing the large hand and the small hand to rotate when the control means is actuated by the intended user; a radio receiver enabled to receive radio waves that carry measurements of glucose and extract the measurements of glucose; a processing system configured to input the measurements of glucose from the radio receiver and further to control positions of the large hand and the small hand as a function of the processed measurements of glucose, whereby the large hand is dedicated to display values of the processed measurements of glucose on an outer scale of the analog display and the small hand is dedicated to point to signs printed on the analog display indicating either one of a tendency of the values of the processed measurements to increase or a tendency of the processed measurements to fall over time.

traducir

SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION

NºPublicación: EP3571995A1 27/11/2019

Solicitante:

DEXCOM INC [US]

US_2019357822_A1

Resumen de: EP3571995A1

The present application concerns a method for calibrating a second continuous analyte sensor using sensor data from a first continuous analyte sensor. The method comprises receiving sensor data from a first continuous analyte sensor, wherein the sensor data is indicative of a glucose concentration in a host; determining a conversion function, using a processor module, wherein the conversion function comprises a slope and a baseline, wherein the slope is representative of a sensor sensitivity, converting the sensor data using the conversion function; receiving sensor data from a second continuous analyte sensor; and calibrating the sensor data from the second continuous analyte sensor using the sensor data from the first continuous analyte sensor, including providing calibration information, including data about the sensor sensitivity, to the second continuous analyte sensor to increase its intelligence and enhance its performance.

traducir

Supply and recovery safe container of pen type insulin syringe needle

NºPublicación: KR20190130524A 22/11/2019

Resumen de: KR20190130524A

본 발명은 인슐린 주사 전 펜타입 주사바늘을 보관부에 복수개 보관하고 보관부에 보관된 사용 전 펜타입 주사바늘을 꺼내어 주사하도록 하고 주사 후 사용된 펜타입 주사바늘을 분리하지 않은 상태로 그대로 수거 회수되도록 하여 사용된 주사기의 재사용을 방지할 수 있어 2차감염사고를 미연에 방지할 수 있으며, 보관된 펜타입 주사바늘의 사용이 완료되면 주사 후 사용된 펜타입 주사바늘이 회수된 상태로 용기본체를 그대로 폐기하도록 하여 주사기배럴과 주사기니들의 분리에 따른 불편함을 해결하고 하나의 용기본체를 이용하여 사용 전 펜타입 주사바늘을 보관함과 동시에 사용 후 펜타입 주사바늘을 회수하여 폐기할 수 있어 사용성과 편의성을 향상시킴은 물론 공간활용성을 크게 향상시킬 수 있는 펜타입 주사바늘 공급 및 회수용기가 개시된다.

traducir

ADVANCED CONTINUOUS ANALYTE MONITORING SYSTEM

NºPublicación: US2019350502A1 21/11/2019

Solicitante:

DEXCOM INC [US]

US_2019167169_A1

Resumen de: US2019350502A1

The present invention relates generally to systems and methods for processing, transmitting, and displaying data received from continuous analyte sensor, such as a glucose sensor. In some embodiments, the continuous analyte sensor system comprises a sensor electronics module that includes power saving features. One feature includes a low power measurement circuit that can be switched between a measurement mode and a low power mode, in which charging circuitry continues to apply power to electrodes of a sensor during the low power mode. In addition, the sensor electronics module can be switched between in a low power storage mode higher power operational mode via a switch. The switch can include a reed switch or optical switch, for example. A validation routine can also be implemented to ensure an interrupt signal sent from the switch is valid. The continuous analyte sensor can be physically connected to a sensor electronics module, which is in direct wireless communication with a plurality of different display devices.

traducir

Glucose Multi-Vital-Sign System in an Electronic Medical Records System

NºPublicación: US2019350469A1 21/11/2019

Solicitante:

ARC DEVICES LTD

WO_2019226273_A1

Resumen de: US2019350469A1

A device measures blood glucose levels, temperature, heart rate, heart rate variability, respiration, SpO2, blood flow, blood pressure, total hemoglobin (SpHb), PVi, methemoglobin (SpMet), acoustic respiration rate (RRa), carboxyhemoglobin (SpCO), oxygen reserve index (ORi), oxygen content (SpOC) and/or EEG of a human

traducir

SAFE DRIVING ASSISTANCE SYSTEM

NºPublicación: WO2019221240A1 21/11/2019

Solicitante:

SOSAIKOUSEIKAI CLINICAL FOUNDATION MATSUNAMI RES PARK [JP]

Resumen de: WO2019221240A1

Provided is a safe driving assistance system that provides support for vehicle driving in accordance with the health state of a driver or the psychological state of the driver. The present invention provides a safe driving assistance system equipped with: a wearable terminal equipped with terminal designation information; a first sensor and a second sensor that acquire biometric information of the driver; and a safe driving assistance in-vehicle device that is equipped with a standard determination unit that determines whether the driver is in a state of being capable of driving by comparing permission information for the driver and first biometric information. The standard determination unit determines at least one from among whether the heart rate is at least a prescribed number, whether the change in skin temperature is at least a prescribed number, and whether the increase in quantity of sweat produced is at least a prescribed number, and determines whether the blood glucose level is below a prescribed number. The safe driving assistance in-vehicle device connects to a vehicle control unit that controls a vehicle that the driver is to drive and controls the travel state of the vehicle on the basis of determination results from the standard determination unit.

traducir

MEDICAL DEVICE FOR TREATING DIABETES

NºPublicación: US2019351228A1 21/11/2019

Solicitante:

IMAM ABDULRAHMAN BIN FAISAL UNIV [SA]

Resumen de: US2019351228A1

A medical device containing a sensor, a motor, one or more plates, and a control unit, for treating diabetes. The medical device vibrates the pancreas thereby improving blood and secretory hormone circulation and enhancing the production of insulin.

traducir

MEASURING INSTRUMENT, STORAGE DEVICE, AND MEASUREMENT SYSTEM

NºPublicación: WO2019221166A1 21/11/2019

Solicitante:

JAPAN SCIENCE & TECH AGENCY [JP]

Resumen de: WO2019221166A1

The present invention is a measurement system provided with: a measurement instrument 10 for storing information relating to an amount of electricity generated by a sugar in a bodily fluid or a secretion of an organism, the measurement instrument 10 being mounted to the organism; and a storage device 15 for receiving, using a near-field-type wireless communication method, information relating to the generated electricity amount stored in the measurement instrument 10 when the measurement instrument is stored, the storage device 15 storing the measurement instrument 10.

traducir

Apparatus in Electronic Medical Records Systems that Determine and Communicate Multi-Vital-Signs from Electromagnetic Radiation of a Subject

Nº publicación: US2019350470A1 21/11/2019

Solicitante:

ARC DEVICES LTD [IE]

WO_2019226273_A1

Resumen de: US2019350470A1

In some implementations, an apparatus includes a physiological light monitoring subsystem that includes a source-detector assembly having a first side that has three transmitters of electromagnetic radiation frequencies in ranges of 375-415 nm, 640-680 nm and 920-960 nm frequencies and a first photodiode receiver of electromagnetic radiation in a 350-1100 nm range to measure an amount of electromagnetic radiation that is reflected by a subject, a microprocessor configured to determine an indication of an amount of glucose in the subject calculated from a ratio of electromagnetic radiation received by a first photodiode receiver of electromagnetic radiation in the 350-1100 nm range to measure an amount of electromagnetic radiation that is absorbed by the subject at the 375-415 nm frequency range in comparison to electromagnetic radiation received at the 920-960 nm frequency range, the subject being positioned between the first side and a second side.

traducir

previousPage Página2 de 6 nextPage por página

punteroimgVolver